Therapeutic Vaccines Market is Estimated To Witness High Growth Owing To Rising Focus On Preventive Healthcare
![]() |
Therapeutic Vaccines Market |
Market Overview:
Therapeutic vaccines are biological therapeutics
designed to treat different types of cancers and chronic infectious diseases.
Therapeutic vaccines aim to boost the body's natural defenses to fight diseases
by triggering an immune response. They help the body recognize and destroy
abnormal cells and thereby cure or prevent certain medical conditions. The
advantages of therapeutic vaccines over traditional pharmaceuticals lie in
their disease-preventing capabilities with fewer side effects.
Market key trends:
The rising focus on preventive healthcare has boosted the demand for
therapeutic vaccines globally. With the growing prevalence of cancer and
infectious diseases worldwide, there is mounting focus on vaccine development
to avert diseases. According to the World Health Organization (WHO), infectious
diseases remain one of the leading causes of death globally, with viral
hepatitis, tuberculosis, HIV/AIDS, malaria, and influenza accounting for
significant morbidity and mortality. This is inducing huge research investments
into therapeutic vaccine development. Further, the upcoming patent expiries of
blockbuster biologics offer an opportunity for therapeutic vaccine makers to
capture significant market shares.
Porter’s Analysis
Threat of new entrants: The high capital requirement for R&D and clinical
trials poses a barrier for new players. However, collaborations allow smaller
biotech companies to develop new vaccines.
Bargaining power of buyers: Individual customers have little bargaining power
due to availability of few substitutes and life-saving nature of vaccines.
However, large buyers like governments negotiate for lower prices in public
procurement.
Bargaining power of suppliers: Few large companies dominate the supply of core
vaccine technologies and antigens. This gives them strong positions in
negotiating licensing deals and supply contracts.
Threat of new substitutes: New immunotherapy approaches pose competition but
traditional vaccines still have advantages of lower costs and easier administration
and storage.
Competitive rivalry: Intense competition exists among large players to develop
innovative new vaccines due to attractive market potential.
SWOT Analysis
Strengths: Large lucrative market and growing research into mechanisms.
Established production and distribution infrastructure.
Weaknesses: High R&D costs and regulatory compliance requirements. Limited
success rate of new vaccine candidates.
Opportunities: Increasing awareness and demand for personalised medicine.
Expanding applications in oncology and infectious diseases.
Threats: Threat from low-cost generics and biosimilars. Stringent regulatory
approvals can delay market entry.
Key Takeaways
The global Therapeutic
Vaccines Market Demand is expected to witness high growth, exhibiting CAGR of 34% over the forecast period,
due to increasing demand for personalized healthcare. North America currently
dominates the market due to presence of major players and increasing adoption.
However, Asia Pacific is expected to grow at the fastest pace due to rising
healthcare expenditure and demand.
Regional analysis: North America is the largest therapeutic vaccines market
currently owing to availability of advanced healthcare facilities and growing
adoption of personalized medicine in the US. However, Asia Pacific region is
expected to provide lucrative growth opportunities during the forecast period
with China, India and Japan being major markets. This is attributed to
improving access to healthcare, rising healthcare spending and increasing
demand for quality medical treatments in the region.
Key players: Key players operating in the therapeutic vaccines market include
Phio Pharmaceuticals Corp., GSK plc., Merck & Co., Inc., Pfizer Inc., and
Agenus Inc. Major players are focusing on collaborations to develop novel
candidates and technologies. They are also investing in expanding manufacturing
facilities and sales networks to strengthen global market presence.
Read
More:
Comments
Post a Comment